Plazomicin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Plazomicin" in German language version.

refsWebsite

Global rank German rank

5doi.org

2^nd place

3^rd place

3nih.gov

4^th place

7^th place

1zemdri.com

low place

1globenewswire.com

2,614^th place

3,424^th place

1biocentury.com

low place

1fda.gov

447^th place

751^st place

1medscape.com

719^th place

1,553^rd place

biocentury.com

Jennie Walters: FDA approves plazomicin for cUTI, but not blood infections. Biocentury, 8. Januar 2015, abgerufen am 12. März 2019 (englisch).

doi.org

James B Aggen, Eliana S Armstrong, Adam A Goldblum, Paola Dozzo, Martin S Linsell: Synthesis and spectrum of the neoglycoside ACHN-490. In: Antimicrobial Agents and Chemotherapy. Band 54, Nr. 11, November 2010, S. 4636–4642, doi:10.1128/AAC.00572-10, PMID 20805391, PMC 2976124 (freier Volltext).
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, Brandon Findlay, Frank Schweizer: Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. In: Expert Review of Anti-Infective Therapy. Band 10, Nr. 4, April 2012, S. 459–473, doi:10.1586/eri.12.25, PMID 22512755.
Cristina García-Salguero, Iciar Rodríguez-Avial, Juan J Picazo, Esther Culebras: Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii? In: Antimicrobial Agents and Chemotherapy. Band 59, Nr. 10, Oktober 2015, S. 5959–5966, doi:10.1128/AAC.00873-15, PMID 26169398, PMC 4576036 (freier Volltext).
James A. McKinnell, Jamie P. Dwyer, George H. Talbot, Lynn E. Connolly, Ian Friedland: Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae. In: New England Journal of Medicine. Band 380, Nr. 8, 21. Februar 2019, S. 791–793, doi:10.1056/NEJMc1807634.
Florian M E Wagenlehner, Daniel J Cloutier, Allison S Komirenko, Deborah S Cebrik, Kevin M Krause: Once-Daily Plazomicin for Complicated Urinary Tract Infections. In: New England Journal of Medicine. Band 380, Nr. 8, 21. Februar 2019, S. 729–740, doi:10.1056/NEJMoa1801467.

fda.gov

accessdata.fda.gov

CENTER FOR DRUG EVALUATION AND RESEARCH: Drug Approval Package: ZEMDRI (plazomicin). (PDF) FDA, 27. Oktober 2017, abgerufen am 12. März 2019 (englisch).

globenewswire.com

Candice Knoll: Achaogen Announces Plazomicin Granted QIDP Designation by FDA. GlobeNewswire, 8. Januar 2015, abgerufen am 12. März 2019 (englisch).

medscape.com

Medscape Log In. In: www.medscape.com. Abgerufen am 3. Juli 2018 (englisch).

nih.gov

ncbi.nlm.nih.gov

James B Aggen, Eliana S Armstrong, Adam A Goldblum, Paola Dozzo, Martin S Linsell: Synthesis and spectrum of the neoglycoside ACHN-490. In: Antimicrobial Agents and Chemotherapy. Band 54, Nr. 11, November 2010, S. 4636–4642, doi:10.1128/AAC.00572-10, PMID 20805391, PMC 2976124 (freier Volltext).
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, Brandon Findlay, Frank Schweizer: Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. In: Expert Review of Anti-Infective Therapy. Band 10, Nr. 4, April 2012, S. 459–473, doi:10.1586/eri.12.25, PMID 22512755.
Cristina García-Salguero, Iciar Rodríguez-Avial, Juan J Picazo, Esther Culebras: Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii? In: Antimicrobial Agents and Chemotherapy. Band 59, Nr. 10, Oktober 2015, S. 5959–5966, doi:10.1128/AAC.00873-15, PMID 26169398, PMC 4576036 (freier Volltext).

zemdri.com

ZEMDRI (plazomicin) Injection. For adult patients with cUTI, including pyelonephritis, due to certain Enterobacteriaceae. ACHAOGEN,, Oktober 2018, abgerufen am 12. März 2019 (englisch).